Johnson & Johnson Price to Book Ratio 2010-2024 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of April 17, 2024 is 5.06.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-04-17 |
144.77 |
|
5.07 |
| 2023-12-31 |
155.56 |
$28.57 |
5.44 |
| 2023-09-30 |
153.36 |
$29.59 |
5.18 |
| 2023-06-30 |
161.82 |
$29.41 |
5.50 |
| 2023-03-31 |
150.39 |
$27.27 |
5.51 |
| 2022-12-31 |
170.20 |
$29.39 |
5.79 |
| 2022-09-30 |
156.39 |
$28.51 |
5.49 |
| 2022-06-30 |
168.80 |
$29.04 |
5.81 |
| 2022-03-31 |
167.48 |
$28.41 |
5.89 |
| 2021-12-31 |
160.62 |
$28.16 |
5.70 |
| 2021-09-30 |
150.63 |
$26.69 |
5.64 |
| 2021-03-31 |
151.44 |
$25.01 |
6.06 |
| 2020-12-31 |
144.12 |
$24.04 |
6.00 |
| 2020-09-30 |
135.38 |
$24.49 |
5.53 |
| 2020-06-30 |
127.04 |
$23.92 |
5.31 |
| 2020-03-31 |
117.63 |
$23.28 |
5.05 |
| 2019-12-31 |
130.01 |
$22.59 |
5.75 |
| 2019-09-30 |
114.52 |
$22.13 |
5.18 |
| 2019-06-30 |
123.28 |
$23.01 |
5.36 |
| 2019-03-31 |
122.89 |
$22.20 |
5.54 |
| 2018-12-31 |
112.71 |
$22.44 |
5.02 |
| 2021-06-30 |
152.74 |
$26.44 |
5.78 |
| 2018-09-30 |
119.91 |
$24.09 |
4.98 |
| 2018-06-30 |
104.60 |
$23.45 |
4.46 |
| 2018-03-31 |
109.66 |
$23.58 |
4.65 |
| 2017-12-31 |
118.81 |
$22.43 |
5.30 |
| 2017-09-30 |
109.88 |
$27.55 |
3.99 |
| 2017-06-30 |
111.10 |
$26.78 |
4.15 |
| 2017-03-31 |
103.92 |
$26.10 |
3.98 |
| 2016-12-31 |
95.50 |
$26.02 |
3.67 |
| 2016-09-30 |
97.25 |
$26.73 |
3.64 |
| 2016-06-30 |
99.20 |
$26.47 |
3.75 |
| 2016-03-31 |
87.86 |
$26.40 |
3.33 |
| 2015-12-31 |
82.81 |
$25.82 |
3.21 |
| 2015-09-30 |
74.71 |
$25.86 |
2.89 |
| 2015-06-30 |
77.39 |
$25.69 |
3.01 |
| 2015-03-31 |
79.31 |
$24.45 |
3.24 |
| 2014-12-31 |
81.86 |
$25.06 |
3.27 |
| 2014-09-30 |
82.91 |
$27.31 |
3.04 |
| 2014-06-30 |
80.83 |
$27.65 |
2.92 |
| 2014-03-31 |
75.37 |
$27.08 |
2.78 |
| 2013-12-31 |
69.77 |
$26.25 |
2.66 |
| 2013-09-30 |
65.58 |
$24.75 |
2.65 |
| 2013-06-30 |
64.47 |
$24.75 |
2.60 |
| 2013-03-31 |
60.76 |
$23.85 |
2.55 |
| 2012-12-31 |
51.83 |
$23.33 |
2.22 |
| 2012-09-30 |
50.51 |
$23.08 |
2.19 |
| 2012-06-30 |
49.07 |
$21.97 |
2.23 |
| 2012-03-31 |
47.45 |
$22.35 |
2.12 |
| 2011-12-31 |
46.77 |
$20.95 |
2.23 |
| 2011-09-30 |
45.00 |
$22.52 |
2.00 |
| 2011-06-30 |
46.59 |
$22.67 |
2.05 |
| 2011-03-31 |
41.14 |
$21.86 |
1.88 |
| 2010-12-31 |
42.56 |
$20.66 |
2.06 |
| 2010-09-30 |
42.27 |
$20.85 |
2.03 |
| 2010-06-30 |
39.91 |
$19.19 |
2.08 |
| 2010-03-31 |
43.66 |
$19.19 |
2.28 |
| 2009-12-31 |
42.81 |
$18.37 |
2.33 |
| 2009-09-30 |
40.15 |
$18.27 |
2.20 |
| 2009-06-30 |
37.16 |
$16.79 |
2.21 |
| 2009-03-31 |
34.10 |
$15.87 |
2.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$348.093B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
